We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+6.62%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$296B
AUM Growth
+$22.5B
Cap. Flow
+$7.07B
Cap. Flow %
2.39%
Top 10 Hldgs %
14.04%
Holding
10,482
New
945
Increased
3,995
Reduced
3,455
Closed
1,657

Sector Composition

Rank Sector Weight
1 Technology 13.25%
2 Financials 6.72%
3 Healthcare 6.58%
4 Consumer Discretionary 5.35%
5 Industrials 4.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGLS
7401
DELISTED
Regulus Therapeutics
RGLS
$5.31K ﹤0.01%
3,612
+1,874
+108% +$2.5K
INVZ icon
7402
Innoviz Technologies
INVZ
$88.8M
$5.3K ﹤0.01%
1,865
+865
+87% +$2.39K
PBHC icon
7403
Pathfinder Bancorp
PBHC
$102M
$5.3K ﹤0.01%
380
+379
+37,900% +$5.39K
EXFY icon
7404
Expensify
EXFY
$195M
$5.27K ﹤0.01%
660
-1,424
-68% -$10.4K
STKH
7405
Steakholder Foods
STKH
$1.52M
$5.25K ﹤0.01%
5
BVS icon
7406
Bioventus
BVS
$1.03B
$5.23K ﹤0.01%
1,809
-13,918
-88% -$26.7K
TSHA icon
7407
Taysha Gene Therapies
TSHA
$1.86B
$5.23K ﹤0.01%
7,909
+4,359
+123% +$3.16K
PRFD icon
7408
PIMCO Preferred and Capital Securities Active Exchange-Traded Fund
PRFD
$237M
$5.22K ﹤0.01%
112
-348
-76% -$16.2K
HBB icon
7409
Hamilton Beach Brands
HBB
$323M
$5.22K ﹤0.01%
540
-1
-0.2% -$10
MPU icon
7410
Mega Matrix
MPU
$14.8M
$5.19K ﹤0.01%
3,993
+1,193
+43% +$1.87K
LIPO
7411
DELISTED
Lipella Pharmaceuticals
LIPO
$5.18K ﹤0.01%
303
+201
+197% +$3.14K
BAD
7412
DELISTED
B.A.D. ETF
BAD
$5.16K ﹤0.01%
404
+118
+41% +$1.51K
MTNB icon
7413
Matinas BioPharma
MTNB
$1.76M
$5.15K ﹤0.01%
+286
New +$6.67K
BCLI
7414
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$5.15K ﹤0.01%
167
-333
-67% -$13.8K
CLOV icon
7415
Clover Health Investments
CLOV
$2.18B
$5.14K ﹤0.01%
5,726
+2,226
+64% +$1.97K
DWMC
7416
DELISTED
AdvisorShares Dorsey Wright Micro-Cap ETF
DWMC
$5.13K ﹤0.01%
+159
New +$4.9K
SPKX
7417
DELISTED
ConvexityShares 1X SPIKES Futures ETF
SPKX
$5.12K ﹤0.01%
+530
New +$7.14K
CAVA icon
7418
CAVA Group
CAVA
$7.71B
$5.12K ﹤0.01%
+125
New +$5.15K
RHRX icon
7419
RH Tactical Rotation ETF
RHRX
$40.2M
$5.09K ﹤0.01%
+405
New +$4.85K
SER icon
7420
Serina Therapeutics
SER
$33.4M
$5.06K ﹤0.01%
161
+160
+16,000% +$3.42K
ATXG icon
7421
Addentax Group
ATXG
$3.36M
$5.06K ﹤0.01%
+51
New +$6.17K
HYGI
7422
DELISTED
iShares Inflation Hedged High Yield Bond ETF
HYGI
$5.06K ﹤0.01%
+200
New +$5.01K
INCM icon
7423
Franklin Income Focus ETF
INCM
$1.73B
$5.05K ﹤0.01%
+200
New +$5.03K
ESP icon
7424
Espey Mfg & Electronics Corp
ESP
$184M
$5.02K ﹤0.01%
300
-406
-58% -$7.86K
CNDA
7425
DELISTED
Concord Acquisition Corp II
CNDA
$5.02K ﹤0.01%
+489
New +$4.99K

Similar funds

UBS Group's Q2 2023 Portfolio in Review

As of Q2 2023, UBS Group held 10,482 positions worth $296B, up 8.2% from $274B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS Group's Q2 2023 filing shows 945 new, 3,995 increased, 3,455 reduced and 1,657 closed positions. Its largest new stake was Global X Emerging Markets Great Consumer ETF: 1,048,148 shares worth $26.1M. The largest sale was UBS Group, an estimated $3.79B.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2023 buy was Global X Emerging Markets Great Consumer ETF: 1,048,148 shares worth $26.1M.
  • UBS Group added most to State Street Financial Select Sector SPDR ETF in Q2 2023, an estimated $456M increase.
  • UBS Group's biggest Q2 2023 reduction was UBS Group, cutting an estimated $3.79B.
  • UBS Group fully exited DCP Midstream, LP in Q2 2023, selling an estimated $148M.
  • UBS Group's ten largest holdings make up 14% of its $296B portfolio in Q2 2023.
  • UBS Group opened 945 new positions and closed 1,657 in Q2 2023.
  • UBS Group's portfolio value rose 8.2% quarter-over-quarter to $296B.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.